ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,53
-0,80%
Dow Jones
40 682,47
1,17%
DAX
18 492,72
-0,58%
Brent Oil
83,08
-1,49%
Bitcoin
63 631,49
-1,89%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
06/09/202314h00PR Newswire (US)Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
05/09/202313h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
05/09/202313h00PR Newswire (US)INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MACNASDAQ:INSMInsmed Inc
04/08/202314h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
03/08/202313h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INSMInsmed Inc
03/08/202313h30PR Newswire (US)Insmed Reports Second-Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
20/07/202314h00PR Newswire (US)Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023NASDAQ:INSMInsmed Inc
13/07/202322h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
11/07/202322h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
07/07/202322h05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INSMInsmed Inc
15/06/202322h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
07/06/202314h00PR Newswire (US)Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
22/05/202322h05PR Newswire (US)Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International ConferenceNASDAQ:INSMInsmed Inc
19/05/202322h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
15/05/202319h52Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:INSMInsmed Inc
11/05/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
08/05/202313h30PR Newswire (US)Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"NASDAQ:INSMInsmed Inc
04/05/202313h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
04/05/202313h30PR Newswire (US)Insmed Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
24/04/202314h00PR Newswire (US)Insmed to Host Investor and Analyst Event on May 8, 2023NASDAQ:INSMInsmed Inc
20/04/202314h00PR Newswire (US)Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023NASDAQ:INSMInsmed Inc
31/03/202322h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
31/03/202322h10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
31/03/202314h00PR Newswire (US)Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in BronchiectasisNASDAQ:INSMInsmed Inc
01/03/202314h00PR Newswire (US)Insmed To Present at Two March ConferencesNASDAQ:INSMInsmed Inc
23/02/202313h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
23/02/202313h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
14/02/202322h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
14/02/202318h44Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INSMInsmed Inc
09/02/202314h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

BIT
UB6DC3
Unicredit Bank
BIT
XLPS
Invesco Consumer Staples...
LSE
SPED
Ivz Sp Eqw D
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés